Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704724 | SCV000714709 | likely benign | not provided | 2020-12-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000687377 | SCV000814941 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317347 | SCV000851220 | likely benign | Inborn genetic diseases | 2017-10-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
New York Genome Center | RCV000720343 | SCV001431115 | uncertain significance | Seizure | 2019-11-12 | no assertion criteria provided | clinical testing |